ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Clinical trials for ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA explained in plain language.
Never miss a new study
Get alerted when new ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA trials appear
Sign up with your email to follow new studies for ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 33-Minute test could speed up deadly blood disorder diagnosis
Diagnosis OngoingThis study aims to validate a new, fully automated blood test (HemosIL AcuStar) that measures ADAMTS13 activity, a key marker for diagnosing thrombotic thrombocytopenic purpura (TTP). Current tests are slow and require manual work, which can delay life-saving treatment. Researche…
Matched conditions: ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Sponsor: Fundación Española de Hematología y Hemoterapía • Aim: Diagnosis
Last updated May 18, 2026 11:59 UTC
-
Real-World data on caplacizumab for aTTP: a game changer in treatment?
Knowledge-focused OngoingThis study reviews medical records of 350 adults with acquired thrombotic thrombocytopenic purpura (aTTP) who received caplacizumab. Researchers want to see how doctors decide to use the drug, how well it works outside of clinical trials, and what factors predict complications. T…
Matched conditions: ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Sponsor: University of Cologne • Aim: Knowledge-focused
Last updated May 19, 2026 11:49 UTC